- Record: found
- Abstract: found
- Article: not found
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.
Guillermo M Ruiz-Palacios
1 ,
Irene Pérez-Schael ,
F Raúl Velázquez ,
Hector Abate ,
Thomas Breuer ,
SueAnn Costa Clemens ,
Brigitte Cheuvart ,
Felix Espinoza ,
Paul Gillard ,
Bruce L Innis ,
Yolanda Cervantes ,
Alexandre C Linhares ,
Pío López ,
Mercedes Macías-Parra ,
Eduardo Ortega-Barría ,
Vesta Richardson ,
Doris Maribel Rivera-Medina ,
Luis Rivera ,
Belén Salinas ,
Noris Pavía-Ruz ,
Jorge Salmerón ,
Ricardo Rüttimann ,
Juan Carlos Tinoco ,
Pilar Rubio ,
Ernesto Nuñez ,
M Lourdes Guerrero ,
Juan Pablo Yarzábal ,
Silvia Damaso ,
Nadia Tornieporth ,
Xavier Sáez-Llorens ,
Rodrigo F Vergara ,
Timo Vesikari ,
Alain Bouckenooghe ,
Ralf Clemens ,
Béatrice De Vos ,
Miguel O'Ryan
Jan 05 2006
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The safety and efficacy of an attenuated G1P[8] human rotavirus (HRV) vaccine were tested in a randomized, double-blind, phase 3 trial.